openPR Logo
Press release

Drexel Morgan Advisors Achieves Record-Breaking 2024 with 195 Companies Successfully Assisted

08-01-2025 11:28 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Drexel Morgan Advisors Achieves Record-Breaking 2024 with 195

New York, NY - Drexel Morgan Advisors [https://www.drexelmorganadvisors.com/], a leading boutique investment banking firm, has announced its most successful year to date, having assisted 195 companies in securing capital and strategic transactions throughout 2024. This milestone represents a 47% increase over the previous year and solidifies the firm's position as a premier advisor for growth-oriented enterprises seeking institutional capital.

The record achievement spans multiple sectors and transaction sizes, from early-stage funding rounds to complex multi-jurisdictional deals exceeding $50 million. Drexel Morgan's comprehensive approach to deal execution and its extensive institutional network enabled the firm to maintain an industry-leading success rate of 89% across all mandates.

"Reaching 195 successful transactions in a single year reflects not just our team's dedication, but the trust that companies place in our ability to deliver results," said Jonathan Drexel, Senior Managing Partner. "Each deal represents a unique challenge, and our track record demonstrates our capacity to navigate complex capital markets regardless of economic conditions."

Diverse Transaction Portfolio

The 195 companies assisted in 2024 represented a broad spectrum of industries, including technology, healthcare, renewable energy, manufacturing, and financial services. Transaction values ranged from $1.2 million seed rounds to a landmark $125 million growth capital raise for a European clean technology company.

Notable achievements from 2024 include facilitating 67 first-time institutional funding rounds, supporting 34 international cross-border transactions, and executing 28 strategic exits that generated combined returns exceeding $2.1 billion for investors and founders.

The firm's ability to maintain consistent execution velocity, even during periods of market volatility, has distinguished it from larger investment banks that often struggle with resource allocation across smaller deals.

Institutional Network Expansion

Throughout 2024, Drexel Morgan expanded its institutional relationships by 23%, adding sovereign wealth funds from the Nordic region, family offices from Southeast Asia, and specialized debt funds focused on infrastructure development. This network expansion directly contributed to the firm's ability to match companies with precisely aligned capital sources.

"Our institutional partners know that when we present an opportunity, it has been thoroughly vetted and strategically positioned," Drexel noted. "This reputation for quality deal flow is what allows us to access capital sources that remain closed to most advisory firms."

Market Leadership Recognition

The record year has positioned Drexel Morgan among the top-performing boutique investment banks globally. Industry publications have recognized the firm's consistent execution and innovative use of technology in deal sourcing and investor relations.

The firm's proprietary deal management platform, enhanced with AI-driven matching algorithms, processed over 3,400 initial inquiries in 2024, ultimately leading to the 195 successful transactions.

About Drexel Morgan Advisors

Drexel Morgan Advisors specializes in connecting growth-stage companies with institutional capital through strategic advisory services and transaction execution. The firm's commitment to precision, integrity, and results has made it a trusted partner for companies seeking to scale their operations.

For inquiries, contact: Jonathan Drexelmedia@drexelmorganadvisors.com [mailto:media@drexelmorganadvisors.com] +1 646-801-5838

Media Contact
Company Name: Drexel Morgan Advisors
Contact Person: Jonathan Drexel
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=drexel-morgan-advisors-achieves-recordbreaking-2024-with-195-companies-successfully-assisted]
Phone: +1 646-801-5838
Country: United States
Website: https://www.drexelmorganadvisors.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drexel Morgan Advisors Achieves Record-Breaking 2024 with 195 Companies Successfully Assisted here

News-ID: 4130326 • Views:

More Releases from ABNewswire

Triple-Negative Breast Cancer Clinical Trial Arena Broadens With 170+ Pipeline Candidates, Reports DelveInsight
Triple-Negative Breast Cancer Clinical Trial Arena Broadens With 170+ Pipeline C …
A growing number of innovative therapies for triple-negative breast cancer (TNBC) - including TECENTRIQ (Hoffmann-La Roche), IPI-549 (Infinity Pharmaceuticals), Leronlimab (CytoDyn), MDNA11 (Medicenna Therapeutics), VIP236 (Vincerx Pharma), and CFI-400945 (Treadwell Therapeutics) - are expected to play a pivotal role in driving market growth and reshaping the TNBC treatment paradigm. DelveInsight's "Triple Negative Breast Cancer Pipeline Insight" presents a comprehensive assessment of more than 165 companies and over 170 drug candidates currently
Colorectal Cancer Competitive Landscape: 195+ Companies Advancing 200+ Clinical-Stage Therapies Across Global Trials, Reports DelveInsight
Colorectal Cancer Competitive Landscape: 195+ Companies Advancing 200+ Clinical- …
Leading companies active in the colorectal cancer space include Nektar Therapeutics, ALX Oncology Inc., Processa Pharmaceuticals, Guojian Pharmaceutical, Gritstone Bio, Daiichi Sankyo, Novartis Pharmaceuticals, Shanghai Henlius Biotech, Sumitomo Pharma Oncology, Purple Biotech Ltd., Amgen, Mirati Therapeutics, Plus Therapeutics, Sparrow Pharmaceuticals, Sirnaomics, G1 Therapeutics, Apollomics, and several others. According to DelveInsight's latest evaluation, the "Colorectal Cancer Pipeline Insight" report delivers a comprehensive analysis of both the clinical and commercial environment. The study
Muscle Invasive Bladder Cancer Competitive Landscape: Insights Into 10+ Companies, 10+ Pipeline Drugs, and Phase I-III Clinical Trials, analyses DelveInsight
Muscle Invasive Bladder Cancer Competitive Landscape: Insights Into 10+ Companie …
Leading companies operating in the Muscle Invasive Bladder Cancer (MIBC) space include Merck Sharp & Dohme LLC, Aura Biosciences, Janssen Research & Development, LLC, Asieris Pharmaceuticals, RemeGen Co., Ltd., along with several other global innovators. The Muscle Invasive Bladder Cancer pipeline is witnessing rapid growth, with over 10 biopharmaceutical companies worldwide such as Merck, Janssen, Aura Biosciences, AstraZeneca, Roche, and RemeGen advancing next-generation therapies. Prominent pipeline candidates including AU-011, TAR-200, KEYNOTE-905/EV-303,
Severe Asthma Clinical Trial Analysis: In-Depth Analysis of 50+ Novel Therapies Being Advanced by 40+ Companies, Reports DelveInsight
Severe Asthma Clinical Trial Analysis: In-Depth Analysis of 50+ Novel Therapies …
Prominent companies actively shaping the severe asthma treatment space include Kinaset Therapeutics, Bio-Thera Solutions, CSPC ZhongQi Pharmaceutical Technology, AB Science, GlaxoSmithKline, Oneness Biotech, Biosion, Lanier Biotherapeutics, Kymera Therapeutics, Suzhou Connect Biopharmaceuticals, Upstream Bio, Teva Branded Pharmaceutical Industries, among others. DelveInsight's "Severe Asthma Pipeline Insight" report delivers a comprehensive assessment of the global severe asthma pipeline. The report evaluates 40+ companies and 50+ pipeline therapies, offering extensive commercial and clinical insights across

All 5 Releases


More Releases for Drexel

Crystron Technologies Announces Sponsored Research Collaboration with Drexel Uni …
Chesterbrook, PA, USA | February 06, 2026 -- Crystron Technologies Inc. announced a sponsored research collaboration with Drexel University and Wesley Chang, PhD, an assistant professor of mechanical engineering and mechanics in Drexel's College of Engineering and director of its Electrochemical Dynamics Laboratory, to support the continued advancement of Crystron's integrated cathode-electrode innovation. The collaboration applies the Lab's system-level battery diagnostics and mechanics-informed analytical methods to evaluate how advanced battery architectures
Drexel Morgan Advisors Powers 2025 Surge in AI-Focused Fintech Capital Raises
Image: https://www.prexhibition.com/public/photo/ec9857339c492d4188aaae62ee9a1b3b.jpeg New York, NY - August 7, 2025 - As AI becomes the engine of innovation across financial services, Drexel Morgan Advisors is leading the way in fueling that momentum with record-setting capital raises for next-gen fintech ventures. The firm has emerged as a key player in matching AI-driven fintech founders with the capital they need to scale breakthrough technologies-ranging from intelligent fraud detection to real-time transaction systems and adaptive
Drexel Morgan Advisors Launches Dedicated Asia-Pacific Division to Capture Cross …
New York, NY - August 5th, 2025 - Drexel Morgan Advisors has announced the establishment of its Asia-Pacific division, marking a strategic expansion into one of the world's most dynamic capital markets. The new division will focus on facilitating cross-border transactions between North American companies and Asian institutional investors, while also supporting Asian enterprises seeking capital from Western institutions. The Asia-Pacific initiative represents Drexel Morgan's response to increasing demand for sophisticated
Metal Fascia System Market to See Booming Growth 2025-2032 | Carlisle, Hickman, …
The latest study report by Coherent Market Insights, titled "Metal Fascia System Market Size, Share & Trends Forecast 2025-2032", this comprehensive analysis delivers vital insights into both global and regional market dynamics expected to shape the industry between 2025 and 2032. The report delves into the competitive landscape, value chain, leading market segments, cross-regional developments, and evolving regulatory and technological trends. Serving as a strategic resource for business leaders, policymakers,
Compatibility Agent market: Reliable Market Size and Share Forecasts up to 2028 …
"The global Compatibility Agent Market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Compatibility Agent Market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global
Fabric Sofa Market Is Booming Worldwide: American Leather, Drexel Heritage, Ashl …
A new business intelligence report released by Advance Market Analytics with title "Global Fabric Sofa Market Insights, Forecast to 2025" has abilities to raise as the most significant market worldwide as it has remained playing a remarkable role in establishing progressive impacts on the universal economy. The Global Fabric Sofa Market Report offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived